Navigation Links
Image Solutions, Inc. Acquires Zurich Biostatistics, Inc.
Date:9/6/2007

and programmers, ISI is able to help clients create statistical plans, conduct analyses and assist in the preparation of reports to avoid these pitfalls. Companies are also able to achieve more effective collaboration between statisticians and medical writers, speeding time to final CSR.

ZBI's core capabilities in biometrics analysis support ISI's commitment to complete, holistic regulatory submissions. Existing clients of both ISI and ZBI now have instant access to this approach and capability.

ISI is a pioneer in modernizing the regulatory submission process. The company enabled the first-ever electronic new drug application to the FDA and is at the forefront of the industry's move to adopting the electronic Common Technical Document (eCTD), the new drug application standard that will be required by the FDA at the end of 2007.

About Image Solutions, Inc.

Founded in 1992, Image Solutions, Inc. (ISI) is a proven market leader in providing submissions solutions, process services and consulting to Life Sciences companies as a way to improve clinical and regulatory processes that bring new medicines to market. ISI was among the first professional services firm to deliver electronic submissions to the industry and since has delivered more than 1,000 electronic submissions and 400 eCTD submissions. ISI serves the top 50 pharmaceutical and biotech organizations as well as the top companies in other regulated industries.

ISI is a privately held company with headquarters in Whippany, New Jersey and operations throughout the U.S., Europe and Asia. ISI also remains committed to giving back to society and sharing its success with others by donating 10 percent of annual net profits to over 20 recognized charitable organizations. For more information, visit the company Web site at http://www.imagesolutions.com.

Press Contacts:

Lisa Meyer Kurt Rossle
'/>"/>

SOURCE Image Solutions, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/6/2009)..., Proves significance of AHCC for maintaining a he... A recently published study in Nut... at Kansai Medical University in Osaka, Japan has ...) enhances immune function by increasing the numbe...the immune system responsible for presenting forei...
(Date:1/6/2009)..., CAMBRIDGE, Mass., Jan. 6 Cequent...novel products to deliver RNAi-based treatments to...he company has recently completed a successful tox...dministered tk RNAi therapeutic targeting the pri...ial adenomatous polyposis). FAP is an inherited ga...
(Date:1/5/2009)..., BETHESDA, Md., Jan. 5 /PRNewswire-FirstCall/...ceutical company developing novel, proprietary,an... and autoimmune diseases,provides an outlook on ... Micromet intends to provide an update on its re...events: , -- April 12 to 16, 2009: Update o...
(Date:12/29/2008)..., BETHESDA, Md., Dec. 29 /PRNewswire-USNewswire/ -...uman Research Protection was announced today by Dr...he Health Improvement Institute. , , The winne...as M.D. Anderson Cancer Center -- for its best ... This program provides for 1) enhanced human subj...
Breaking Medicine Technology:Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 2Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 3Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 2Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 3Micromet Key Events for 2009 2Micromet Key Events for 2009 3Micromet Key Events for 2009 4Micromet Key Events for 2009 52008 Human Research Protection Award Recipients Announced 2EDS Chosen to Manage Combat Veteran Call Center for Department of Veterans Affairs 18910 1EDS Chosen to Manage Combat Veteran Call Center for Department of Veterans Affairs 18910 2Smart Balance to Webcast Presentation at Goldman Sachs Consumer Products Symposium 18908 1Smart Balance to Webcast Presentation at Goldman Sachs Consumer Products Symposium 18908 2American Red Cross of Southeastern Michigan Celebrates Outstanding Volunteers for Years of Service 18906 1American Red Cross of Southeastern Michigan Celebrates Outstanding Volunteers for Years of Service 18906 2Traditional Medicare Benefit Information Soon to be Available Online to Doctors and Hospitals through Blue Cross Blue Shield of Michigan Web Portal 18904 1Traditional Medicare Benefit Information Soon to be Available Online to Doctors and Hospitals through Blue Cross Blue Shield of Michigan Web Portal 18904 2Traditional Medicare Benefit Information Soon to be Available Online to Doctors and Hospitals through Blue Cross Blue Shield of Michigan Web Portal 18904 3
...New Data from Phase III Intergroupe Francophone du...IDGE, Mass., July 02, 2007 /PRNewswire-FirstCall/ ... that new data were,presented on the comparative P... therapy in newly diagnosed multiple myeloma (MM),...transplantation,(SCT), the VELCADE based therapy p...
...Pain Reductions Observed at Eight Weeks Sustained ...d -, SOUTH SAN FRANCISCO, Calif., July 02, 2007,/P...ced preliminary,longer-term, follow-up results fro...h Adlea(TM) (formerly 4975) in patients with,moder...substantial,reductions in pain that persisted for ...
Other Medicine Technology:Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 2Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 3Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 4Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 5Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 6Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain,Reductions with Adlea(TM) (formerly 4975) in Osteoarthritis of the,Knee 2Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain,Reductions with Adlea(TM) (formerly 4975) in Osteoarthritis of the,Knee 3Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain,Reductions with Adlea(TM) (formerly 4975) in Osteoarthritis of the,Knee 4Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain,Reductions with Adlea(TM) (formerly 4975) in Osteoarthritis of the,Knee 5
(Date:1/8/2009)...swire-USNewswire/ -- The Alliance for the Prudent ... marketing campaigns by Wal-Mart, Stop and Shop, P...scribed antibiotics to customers. These offers are...ead to increased costs in the form of treatment fa...e public,s need for affordable healthcare is indis...
(Date:1/8/2009)... available that work, CDC officials stress , ...st common strain of flu this season is resistant t...nt health officials said Thursday there is no reas...far has been slow, and that other drugs work well ...cials adopting a watchful attitude for now. , W...
(Date:1/8/2009)...swire/ -- A study released this week showing that ...ultiple chronic diseases shines a much-needed spot...stem to one that focuses on primary and secondary ... the leader in disease prevention. , , (Logo:...TU129LOGO ) , , The study, conducted by Socia...
(Date:1/8/2009)...e Revealed Friday, January 9 , , WASHINGTON, J...mployees International Union (SEIU) President Andy...rnational Executive Board to discuss the forced tr... out of SEIU United Healthcare Workers-West (UHW),...l decision until tomorrow. , , According to rep...
Breaking Medicine News(10 mins):Health News:Antibiotics as Loss Leaders? 2Health News:Common Flu Strain Resistant to Popular Antiviral Drug 2Health News:Common Flu Strain Resistant to Popular Antiviral Drug 3Health News:U.S. Preventive Medicine: Chronic Disease Study Demonstrates Need for Focus on Primary and Secondary Prevention 2Health News:SEIU Decision to Force Transfer of Long-Term Care Members Out of United Healthcare Workers Delayed 2
...llege of Wisconsin Center for Patient Care and Out...reast cancer survivors, who were under the care of...ialist, had a better chance of beating their tumor... researchers found that about two-thirds of elderl...
...ssue of General Dentistry, the AGD’s clinical, pee...ally that of the tongue is harmful and should be a... report describes the condition of a young girl, w...ssive scar tissue formation around the area that w...
... level of awareness about the pill among women. It...the Progestogen-only// pill are not aware that it ...e of intake. Due to this many women are at risk ...ducted among more than 5,700 women throughout Euro...
...substitute, and a highly vulnerable commodity is i...concerns determine what goes into formula milk, wa...e Codex Alimentarius Commission, part of both the ... United Nations and the World Health Organisation,...
Other Medicine News:
Inquire
Built-in convexity means added security and skin protection for recessed, retracted and flush stomas...pre-cut openings. Security and confidence achieved by the internal No-Flowback Valves and soft d
Inquire
Superior comfort and flexibility are achieved through the revolutionary air pocket technology in the dimpled, ultra-thin SoftFlex skin barrier along with a discreet pouch shape and size.
Medicine Products: